Results 171 to 180 of about 857,514 (313)

Sphingolipid signaling in kidney diseases. [PDF]

Am J Physiol Renal Physiol
Li N, Li G.
europepmc   +1 more source

“Diseases of the Kidney.” By W. GIRLING BALL, F.R.C.S.(Eng.) [PDF]

, 1932

openalex   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

RNA-Based Therapies in Kidney Diseases. [PDF]

J Inflamm Res
Hu L, Jin T, Zhang N, Ding J, Li L.
europepmc   +1 more source

Nanobody‐Decorated Lipid Nanoparticles for Enhanced mRNA Delivery to Tumors In Vivo

Advanced Healthcare Materials, EarlyView.
This study presents a targeted mRNA‐LNP platform engineered with anti‐PSMA nanobodies for prostate cancer therapy. Using different in vivo models, the authors demonstrate selective uptake and mRNA delivery in PSMA+ cancer cells. However, while targeting is enhanced, mRNA delivery efficacy is limited by tissue penetration, tumor necrosis, and immune ...
Pol Escudé Martinez de Castilla, Vincenzo Verdi, Willemijn de Voogt, Mariona Estapé Sentí, Arnold C. Koekman, Julian Rietveld, Sven van Kempen, Qiangbing Yang, Juliette van Merris, Guido Jenster, Martin E. van Royen, Marcel H. Fens, Sander A. A. Kooijmans, Wytske M. van Weerden, Guillaume van Niel, Pieter Vader, Raymond M. Schiffelers   +16 more
wiley   +1 more source

The key role of miR‑378 in kidney diseases (Review). [PDF]

Mol Med Rep
Liu Y, Shi S, Cheng T, Wang H, Wang H, Hu Y.   +5 more
europepmc   +1 more source

25. On the co-existence of Granular Disease of the Kidneys, with Pulmonary Consumption; and on the influence of the Strumons Diathesis in predisposing to the Renal Disease [PDF]

THOMAS BEVIL PEACOCK
openalex   +1 more source

Practical Talks on Kidney Disease [PDF]

, 1938

openalex   +1 more source

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

Advanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang, Mengyuan Qian, Yirui Shi, Jiaxu Cao, Min Xu, Xin Wen, Yunxia Yan, Sha Liu, Hongwei Chen, Shanshan Liu, Jun Yang, Lingyun Sun   +11 more
wiley   +1 more source

POS-141 Comparison of Clinical Efficacy of Centrifugal-Membranous Double Filtration Plasmapheresis and Membranous Double Filtration Plasmapheresis on Severe Lupus Nephritis

Kidney International Reports, 2021
J. DONG, Y. Ge, L. Huang, C. Li, L. Kong, L. Huang, W. Fan, B. Wu, W. Hu   +8 more
doaj